Friedreich Ataxia Scientific News
Friedreich Ataxia and close related scientific news. Topics related to rare diseases.
Thursday, December 19, 2019
Electrophysiological evidence for limited progression of the proprioceptive impairment in Friedreich ataxia
›
G. Naeije, M. Bourguignon, V. Wens, B. Marty, S. Goldman, R. Hari, V. Jousmäki, M. Pandolfo, X. De Tiège; Clinical Neurophysiology, 2019, Do...
Wednesday, December 18, 2019
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
›
BOSTON and BALA CYNWYD, Pa., Dec. 18, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (ZFGN) and Chondrial Therapeutics, Inc., today announced they ha...
Chondrial Therapeutics Announces Dosing of First Patients in Phase 1 Clinical Program of CTI-1601 for Treatment of Friedreich’s AtaxiaCTI-1601 granted Rare Pediatric Disease Designation and Fast Track Designation by U.S. FDA
›
BALA CYNWYD, Pa., Dec. 18, 2019 (GLOBE NEWSWIRE) -- Chondrial Therapeutics, a clinical-stage biotechnology company focused on developing tre...
Exicure : Announces First Neurological Development Program in Friedreich's Ataxia and Expands Scientific Advisory Board
›
12/17/2019, CHICAGO - Exicure, Inc. (NASDAQ: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic a...
Tuesday, December 17, 2019
Cellular Stress-Modulating Drugs Can Potentially Be Identified by in Silico Screening with Connectivity Map (CMap)
›
Gao Y, Sungwoo Kim, Lee YI, Lee J; International Journal of Molecular Sciences, 09 Nov 2019, 20(22) DOI: 10.3390/ijms20225601 A target...
‹
›
Home
View web version